Neurocysticercosis uncovered by single-dose albendazole [27]

New England Journal of Medicine

Volumn 356, Issue 12, 2007, Pages 1277-1278

  Garcia, Hector H ^a   Gonzalez, Isidro ^a   Mija, Lizardo ^b  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b INSTITUTO NACIONAL DE CIENCIAS NEUROLÓGICAS   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANALGESIC AGENT; CORTICOSTEROID;

ADULT; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LETTER; NEUROCYSTICERCOSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SINGLE DRUG DOSE;

EID: 33947547433     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc062891     Document Type: Letter

References (5)

1. United Nations. Resolution presented at the 54th World Health Assembly, Geneva, May 19, 2001.
2. Urbani C, Albonico M. Anthelminthic drug safety and drug administration in the control of soil-transmitted helminthiasis in community campaigns. Acta Trop 2003;86:215-21.
3. Montano SM, Villaran MV, Ylquimiche L, et al. Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology 2005;65:229-33.
4. Sanchez AL, Lindback J, Schantz PM, et al. A populationbased, case-control study of Taenia solium taeniasis and cysticercosis. Ann Trop Med Parasitol 1999;93:247-58.
5. Flisser A, Madrazo I, Plancarte A, et al. Neurological symptoms in occult neurocysticercosis after single taeniacidal dose of praziquantel. Lancet 1993;342:748.